PROS1 and COVID-19: Compared with mRNA, recombinant protein, or viral vector vaccines involving only receptor-binding domain (RBD) or spike(S) protein, an advantage of inactivated COVID-19 vaccines may be that they also contain conserved SARS-CoV-2 antigens in addition to S protein [25].